000			02125nam a22003137a 4500
003			OSt
005			20241230145744.0
008			241230b |||||||| |||| 00| 0 hin d
020			_a9781118907276
040			_aNISER LIBRARY _beng _cNISER LIBRARY
041			_aEnglish
082			_a615.32 _bNG-D
100			_aNg, Rick
245			_aDrugs : _bfrom discovery to approval
250			_a3rd ed.
260			_aNew Jersey : _bWiley Blackwell, _c2015
300			_axvi, 536p.
504			_aIncludes bibliographical references and index.
520			_aThe third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The third edition incorporates the latest developments and updates in the pharmaceutical community, provides more comprehensive coverage of topics, and includes more materials and case studies suited to college and university use. Biotechnology is a dynamic field with changes across R&D, clinical trials, manufacturing and regulatory processes, and the third edition of the text provides timely updates for those in this rapidly growing field.
650			_aDrug Discovery
650			_aChemistry, Pharmaceutical
650			_aClinical Trials as Topic _xmethods
650			_aDrug Approval _xlegislation & jurisprudence
650			_aDrug Approval _xmethods
650			_aTechnology, Pharmaceutical
856			_3Table of Contents _uhttps://www.wiley.com/en-be/Drugs%3A+From+Discovery+to+Approval%2C+3rd+Edition-p-9781118907276#tableofcontents-section
856			_3Reviews _uhttps://www.goodreads.com/book/show/23530327-drugs?ref=nav_sb_ss_1_13#CommunityReviews
942			_cBK _2udc
999			_c35525 _d35525